Cited by 583Alzheimer's disease research and treatmentsNeurological Disease Mechanisms and TreatmentsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.

Animal models of neurodegenerative diseases

Open access

Dawson, Ted M., Golde, Todd E., Lagier-Tourenne, Clotilde·2018·Nature Neuroscience

DOI 10.1038/s41593-018-0236-8PMC PMC6615039

Open this paper in CoChat — free account

Abstract

Animal models of adult-onset neurodegenerative diseases have enhanced the understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Nevertheless, our understanding of these disorders and the development of mechanistically designed therapeutics can still benefit from more rigorous use of the models and from generation of animals that more faithfully recapitulate human disease. Here we review the current state of rodent models for Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. We discuss the limitations and utility of current models, issues regarding translatability, and future directions for developing animal models of these human disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41593-018-0236-8

Cites

151 of 151 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Intraneuronal APP, Not Free Aβ Peptides In 3xTg-AD Mice: Implications For Tau Versus Aβ Mediated Alzheimer Neurodegeneration
Winton, M. J., Lee, E. B., Sun, E., Wong, M. M., Leight, S., Zhang, B., Trojanowski, J., & Lee, V. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6637-10.2011 · Cited by 110
Retracted
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Prions
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citation

Show all 151 references

Sorted by citations

Items 101–200 of 583

The need to incorporate aged animals into the preclinical modeling of neurological conditions
Sun, M., McDonald, S. J., Brady, R. D., Collins‐Praino, L. E., Yamakawa, G. R., Monif, M., O'Brien, T. J., CLOUD, G. C., Sobey, C. G., Mychasiuk, R., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.12.027 · Cited by 44
Impact of aging on animal models of Parkinson's disease
Klæstrup, I. H., Just, M. K., Holm, K. L., Alstrup, A. K. O., Romero‐Ramos, M., Borghammer, P., & Berge, N. V. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.909273 · Cited by 44
Aerobic exercise combined with chlorogenic acid exerts neuroprotective effects and reverses cognitive decline in Alzheimer’s disease model mice (APP/PS1) via the SIRT1/ /PGC-1α/PPARγ signaling pathway
Shi, D., Hao, Z., Qi, W., Jiang, F., Liu, K., & Shi, X. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1269952 · Cited by 45
The degree of astrocyte activation is predictive of the incubation time to prion disease
Makarava, N., Mychko, O., Chang, J. C., Molesworth, K., & Baskakov, I. V. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01192-9 · Cited by 43
The pleiotropic roles of autophagy in Alzheimer’s disease: From pathophysiology to therapy
Festa, B. P., Barbosa, A. D., Rob, M., & Rubinsztein, D. C. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.07.011 · Cited by 41
Mitochondrial dysfunction in neurodegenerative diseases: A focus on iPSC-derived neuronal models
Trombetta-Lima, M., Sabogal-Guáqueta, A. M., & Dolga, A. M. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102362 · Cited by 42
Soma and neurite density MRI (SANDI) of the in‐vivo mouse brain and comparison with the Allen Brain Atlas
Ianuş, A., Carvalho, J., Fernandes, F. F., Cruz, R., Chavarrias, C., Palombo, M., & Shemesh, N. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119135 · Cited by 40
Nanotechnological approaches for targeting amyloid-β aggregation with potential for neurodegenerative disease therapy and diagnosis
Shukla, R., Singh, A., Handa, M., Flora, S. J. S., & Kesharwani, P. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.04.011 · Cited by 40
Neuromuscular Development and Disease: Learning From in vitro and in vivo Models
Fralish, Z., Lotz, E. M., Chavez, T., Khodabukus, A., & Bursac, N. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764732 · Cited by 40
Convergent pathways of the gut microbiota–brain axis and neurodegenerative disorders
Gubert, C., Gasparotto, J., & Morais, L. H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac017 · Cited by 40
Biohybrid neural interfaces: improving the biological integration of neural implants
Boulingre, M., Lara, R. P., & Green, R. A. (2023) · Chemical Communications · doi:10.1039/d3cc05006h · Cited by 41
Brain incoming call from glia during neuroinflammation: Roles of extracellular vesicles
D’Egidio, F., Castelli, V., d’Angelo, M., Ammannito, F., Quintiliani, M., & Cimini, A. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106663 · Cited by 41
Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives
Neziri, S., Köseoğlu, A. E., Köseoğlu, G. D., Özgültekin, B., & Özgentürk, N. Ö. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12487 · Cited by 40
Investigating the Structure of Neurotoxic Protein Aggregates Inside Cells
Bäuerlein, F. J. B., Fernández‐Busnadiego, R., & Baumeister, W. P. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.08.007 · Cited by 39
iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine
Pandey, S., Jirásko, M., Lochman, J., Chvátal, A., Dvorakova, M. C., & Kučera, R. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091485 · Cited by 39
Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting
Teli, P., Kale, V. P., & Vaidya, A. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03821-2 · Cited by 37
Pain and aging: A unique challenge in neuroinflammation and behavior
Singh, S. P., Guindon, J., Mody, P. H., Ashworth, G., Kopel, J. J., Chilakapati, S. S., Adogwa, O., Neugebauer, V., & Burton, M. D. (2023) · Molecular Pain · doi:10.1177/17448069231203090 · Cited by 39
The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife
Kilzheimer, A., Hentrich, T., Burkhardt, S., & Schulze-Hentrich, J. M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01328 · Cited by 41
Non-cell autonomous astrocyte-mediated neuronal toxicity in prion diseases
Kushwaha, R., Sinha, A., Makarava, N., Molesworth, K., & Baskakov, I. V. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01123-8 · Cited by 41
Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future
Levin, L. A., Patrick, C., Choudry, N. B., Sharif, N. A., & Goldberg, J. L. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.964197 · Cited by 37
Turquoise killifish: A natural model of age-dependent brain degeneration
de Bakker, D. E. M., & Valenzano, D. R. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102019 · Cited by 36
The Sexual Motivation of Male Rats as a Tool in Animal Models of Human Health Disorders
Biały, M., Bogacki-Rychlik, W., Przybylski, J., & Żera, T. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00257 · Cited by 36
From Mice to Monkeys? Beyond Orthodox Approaches to the Ethics of Animal Model Choice
Walker, R. L., & Eggel, M. (2020) · Animals · doi:10.3390/ani10010077 · Cited by 38
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
Jung, Y. J., Tweedie, D., Scerba, M. T., Kim, D. S., Palmas, M. F., Pisanu, A., Carta, A. R., & Greig, N. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.656921 · Cited by 37
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy
Akanchise, T., & Angelova, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051562 · Cited by 37
Evolving challenges to model human diseases for translational research
Beck, A. P., & Meyerholz, D. K. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03134-3 · Cited by 35
Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders
Jacquet, A. D. R., Denis, H. L., Cicchetti, F., & Alpaugh, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00999-7 · Cited by 36
Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders
Golde, T. E. (2019) · Neuron · doi:10.1016/j.neuron.2019.02.027 · Cited by 45
Self-citation
Isolation, Characterization and Neuroprotective Activity of Folecitin: An In Vivo Study
Farooq, U., Khan, T., Shah, S. A., Hossain, M. S., Ali, Y., Ullah, R., Raziq, N., Shahid, M. M., & Capasso, R. (2021) · Life · doi:10.3390/life11080825 · Cited by 34
Brain Organoids: A Game-Changer for Drug Testing
Giorgi, C., Lombardozzi, G., Ammannito, F., Scenna, M. S., Maceroni, E., Quintiliani, M., d’Angelo, M., Cimini, A., & Castelli, V. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040443 · Cited by 34
3D human brain cell models: New frontiers in disease understanding and drug discovery for neurodegenerative diseases
Korhonen, P., Malm, T., & White, A. R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.012 · Cited by 34
Small Molecule Drugs Targeting Non-Coding RNAs as Treatments for Alzheimer’s Disease and Related Dementias
Nguyen, L. D., Chau, R. K., & Krichevsky, A. M. (2021) · Genes · doi:10.3390/genes12122005 · Cited by 37
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
Boraschi, D., Italiani, P., Migliorini, P., & Bossù, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1128190 · Cited by 38
Rapid and precise genome engineering in a naturally short-lived vertebrate
Nath, R. D., Bedbrook, C. N., Nagvekar, R., Deisseroth, K. A., & Brunet, A. (2023) · eLife · doi:10.7554/elife.80639 · Cited by 33
Alpha-asarone Improves Cognitive Function of APP/PS1 Mice and Reducing Aβ42, P-tau and Neuroinflammation, and Promoting Neuron Survival in the Hippocampus
Zeng, L., Zhang, D., Liu, Q., Zhang, J., Mu, K., Gao, X., Zhang, K., Li, H., Wang, Q., Zheng, Y., et al. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2020.12.026 · Cited by 33
Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP‐43 pathology
Genç, B., Gautam, M., Gözütok, Ö., Dervishi, I., Sanchez, S. S., Goshu, G. M., Koçak, N., Xie, E. F., Silverman, R. B., & Özdi̇nler, P. H. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.336 · Cited by 33
Functional microglia derived from human pluripotent stem cells empower retinal organs
Gao, M.-L., Zhang, X., Han, F., Xu, J. M., Yu, S., Jin, K., & Jin, Z. (2022) · Science China Life Sciences · doi:10.1007/s11427-021-2086-0 · Cited by 33
Redefining microglia states: Lessons and limits of human and mouse models to study microglia states in neurodegenerative diseases
de Soysa, Y., Therrien, M., Walker, A. C., & Stevens, B. (2022) · Seminars in Immunology · doi:10.1016/j.smim.2022.101651 · Cited by 34
The Drosophila blood-brain barrier emerges as a model for understanding human brain diseases
Contreras, E. G., & Klämbt, C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106071 · Cited by 32
Three‐dimensional bioprinting of stem cell‐derived central nervous system cells enables astrocyte growth, vasculogenesis, and enhances neural differentiation/function
Sullivan, M. A., Lane, S., Volkerling, A. M., Engel, M., Werry, E. L., & Kassiou, M. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28470 · Cited by 32
Advances and Challenges in Gene Therapy for Neurodegenerative Diseases: A Systematic Review
García-González, N., Gonçalves-Sánchez, J., Gómez‐Nieto, R., Gonçalves, J. M., & López, D. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312485 · Cited by 39
Preclinical In Vitro and In Vivo Characterization of Synaptic Vesicle 2A–Targeting Compounds Amenable to F-18 Labeling as Potential PET Radioligands for Imaging of Synapse Integrity
Patel, S., Knight, A. C., Krause, S., Teceno, T. J., Tresse, C., Li, S., Cai, Z., Gouasmat, A., Carroll, V. M., Barret, O., et al. (2019) · Molecular Imaging and Biology · doi:10.1007/s11307-019-01428-0 · Cited by 33
CELF2 regulates the species-specific alternative splicing of TREM2
Yanaizu, M., Washizu, C., Nukina, N., Satoh, J., & Kino, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-75057-x · Cited by 32
Non-Coding RNAs as Sensors of Oxidative Stress in Neurodegenerative Diseases
Gámez‐Valero, A., Guisado-Corcoll, A., Herrero‐Lorenzo, M., Solaguren‐Beascoa, M., & Martí, E. (2020) · Antioxidants · doi:10.3390/antiox9111095 · Cited by 34
Frontotemporal dementia: from genetics to therapeutic approaches
Buccellato, F. R., D’Anca, M., Tartaglia, G. M., FABBRO, M. D., & Galimberti, D. (2024) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2024.2349286 · Cited by 32
Intact olfactory memory in the 5xFAD mouse model of Alzheimer’s disease from 3 to 15 months of age
O’Leary, T. P., Stover, K. R., Mantolino, H. M., Darvesh, S., & Brown, R. E. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112731 · Cited by 30
Use of Human Pluripotent Stem Cell-Derived Cells for Neurodegenerative Disease Modeling and Drug Screening Platform
García‐León, J. A., Vitórica, J., & Gutiérrez, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0520 · Cited by 30
Sleep and ageing: from human studies to rodent models
McKillop, L. E., & Vyazovskiy, V. V. (2020) · Current Opinion in Physiology · doi:10.1016/j.cophys.2020.03.004 · Cited by 31
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
Yazar, V., Dawson, V. L., Dawson, T. M., & Kang, S.-U. (2023) · Journal of Parkinson s Disease · doi:10.3233/jpd-223517 · Cited by 29
Self-citation
Microscopic-scale magnetic recording of brain neuronal electrical activity using a diamond quantum sensor
Hansen, N. W., Webb, J. L., Troise, L., Olsson, C., Tomasevic, L., Brinza, O., Achard, J., Staacke, R., Kieschnick, M., Meijer, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39539-y · Cited by 28
Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms
Khan, A. F., & Iturria‐Medina, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03073-w · Cited by 31
Development of two-photon polymerised scaffolds for optical interrogation and neurite guidance of human iPSC-derived cortical neuronal networks
Crowe, J. A., El-Tamer, A., Nagel, D. A., Koroleva, A., Madrid-Wolff, J. A., Olarte, O. E., Sokolovsky, S. G., Estévez-Priego, E., Ludl, A.-A., Soriano, J., et al. (2020) · Lab on a Chip · doi:10.1039/c9lc01209e · Cited by 30
Animal and Cellular Models of Alzheimer’s Disease: Progress, Promise, and Future Approaches
Trujillo‐Estrada, L., Sánchez‐Mejías, E., Sanchez-Varo, R. M., García‐León, J. A., Nuñez‐Diaz, C., Dávila, J. C., Vitórica, J., LaFerla, F. M., Moreno‐González, I., Gutiérrez, A., et al. (2021) · The Neuroscientist · doi:10.1177/10738584211001753 · Cited by 30
T Cell Responses to Neural Autoantigens Are Similar in Alzheimer’s Disease Patients and Age-Matched Healthy Controls
Dhanwani, R., Pham, J. W., Premlal, A. L. R., Frazier, A., Kumar, A., Pero, M. E., Bartolini, F., Dutra, J. R., Marder, K. S., Peters, B., et al. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00874 · Cited by 29
Prospects of green nanotechnology for efficient management of neurodegenerative diseases
Chaudhary, V. (2022) · Frontiers in Nanotechnology · doi:10.3389/fnano.2022.1055708 · Cited by 28
Hybrid magnetic resonance and optoacoustic tomography (MROT) for preclinical neuroimaging
Chen, Z., Gezginer, I., Augath, M., Ren, W., Liu, Y., Ni, R., Deán‐Ben, X. L., & Razansky, D. (2022) · Light Science & Applications · doi:10.1038/s41377-022-01026-w · Cited by 28
Brain banking in the United States and Europe: Importance, challenges, and future trends
Danner, B., Gonzalez, A. D., Corbett, W. C., Alhneif, M., Etemadmoghadam, S., Parker‐Garza, J., & Flanagan, M. E. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae014 · Cited by 27
Honing the Double-Edged Sword: Improving Human iPSC-Microglia Models
Hedegaard, A., Stodolak, S., James, W. S., & Cowley, S. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.614972 · Cited by 29
Dopamine Neuron Diversity: Recent Advances and Current Challenges in Human Stem Cell Models and Single Cell Sequencing
Fiorenzano, A., Sozzi, E., Parmar, M., & Storm, P. (2021) · Cells · doi:10.3390/cells10061366 · Cited by 28
Towards early detection of neurodegenerative diseases: A gut feeling
Makdissi, S., Parsons, B., & Cara, F. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1087091 · Cited by 28
Plant‐derived peptides for the improvement of Alzheimer's disease: Production, functions, and mechanisms
Lin, L., Li, C., Li, T., Zheng, J., Shu, Y., Zhang, J., Shen, Y., & Ren, D. (2023) · Food Frontiers · doi:10.1002/fft2.210 · Cited by 28
The pROS of Autophagy in Neuronal Health
Sedlackova, L., Kelly, G., & Korolchuk, V. I. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.020 · Cited by 28
Microglia across evolution: from conserved origins to functional divergence
Shimizu, T., & Prinz, M. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01368-6 · Cited by 28
The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates
Creekmore, B. C., Chang, Y., & Lee, E. B. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab039 · Cited by 28
Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease
Kshirsagar, S., Alvir, R. V., Hindle, A., Kumar, S., Vijayan, M., Pradeepkiran, J. A., Reddy, A. P., Ramasubramanian, B., & Reddy, P. H. (2022) · Cells · doi:10.3390/cells11040733 · Cited by 27
Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
Villar-Gómez, N., Ojeda-Hernández, D. D., López-Muguruza, E., García-Flores, S., Bonel-García, N., Benito‐Martín, M. S., Selma-Calvo, B., Canales-Aguirre, A. A., Mateos‐Díaz, J. C., Montero‐Escribano, P., et al. (2022) · Cells · doi:10.3390/cells11193095 · Cited by 26
Advances of metallodrug-amyloid β aggregation inhibitors for therapeutic intervention in neurodegenerative diseases: Evaluation of their mechanistic insights and neurotoxicity
Khan, H. Y., Ahmad, A., Hassan, M. N., Khan, Y. H., Arjmand, F., & Khan, R. H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215580 · Cited by 26
Photodynamic studies reveal rapid formation and appreciable turnover of tau inclusions
Croft, C. L., Goodwin, M. S., Ryu, D. H., Lessard, C. B., Tejeda, G., Marrero, M., Vause, A. R., Paterno, G., Cruz, P. E., Lewis, J. M., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02264-9 · Cited by 26
Self-citation
Delivery of neurotrophic factors in the treatment of age-related chronic neurodegenerative diseases
Padmakumar, S., Taha, M. S., Kadakia, E., Bleier, B. S., & Amiji, M. M. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1727443 · Cited by 25
Physical Exercise Modulates Brain Physiology Through a Network of Long- and Short-Range Cellular Interactions
Consorti, A., Marco, I. D., & Sansevero, G. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.710303 · Cited by 27
Approaches for evaluation of novel CPP-based cargo delivery systems
Porosk, L., & Langel, Ü. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1056467 · Cited by 25
Animal Models of Human Disease
Lange, S., & Inal, J. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115821 · Cited by 25
25-hydroxycholesterol promotes brain cytokine production and leukocyte infiltration in a mouse model of lipopolysaccharide-induced neuroinflammation
Romero, J., Toral-Ríos, D., Yu, J., Paul, S. M., & Cashikar, A. G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03233-1 · Cited by 24
Targeting for Success: Demonstrating Proof-of-Concept with Mechanistic Early Phase Clinical Pharmacology Studies for Disease-Modification in Neurodegenerative Disorders
Vissers, M. F. J. M., Heuberger, J. A. A. C., & Groeneveld, G. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041615 · Cited by 24
Microfluidic Platforms to Unravel Mysteries of Alzheimer’s Disease: How Far Have We Come?
Prasanna, P., Rathee, S., Rahul, V., Mandal, D., Goud, M. S. C., Yadav, P., Hawthorne, S. J., Sharma, A., Gupta, P. K., Ojha, S. K., et al. (2021) · Life · doi:10.3390/life11101022 · Cited by 25
Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease
Tan, Z., Garduño, B. M., Fernández‐Aburto, P., Chen, L., Ha, N. M.-L., Cogram, P., Holmes, T. C., & Xu, X. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01481-x · Cited by 30
Pramipexole Inhibits MPP+-Induced Neurotoxicity by miR-494-3p/BDNF
Deng, C., Zhu, J., Yuan, J., Xiang, Y., & Dai, L. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02910-5 · Cited by 24
Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy
Fortin, J. S., Hetak, A. A., Duggan, K. E., Burglass, C. M., Penticoff, H. B., & Schott, H. C. (2021) · Scientific Reports · doi:10.1038/s41598-021-95396-7 · Cited by 24
Role of the Insulin-like Growth Factor System in Neurodegenerative Disease
LEWITT, M. S., & Boyd, G. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084512 · Cited by 25
Advances in human cellular mechanistic understanding and drug discovery of brain organoids for neurodegenerative diseases
Tong, L., Zhang, X., Fu, G., Luo, S., Zhao, Z., Deng, S., Li, C., Cui, Z., Cao, J., Chen, P., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102517 · Cited by 23
The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease
Burbulla, L. F., & Krainc, D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104545 · Cited by 23
Development and Validation of CRISPR Activator Systems for Overexpression of CB1 Receptors in Neurons
Maria, V. D., Moindrot, M., Ryde, M., Bono, A., Quintino, L., & Ledri, M. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00168 · Cited by 23
Rational Design of Novel Therapies for Pantothenate Kinase–Associated Neurodegeneration
Thakur, N., Klopstock, T., Jackowski, S., Kuscer, E., Tricta, F., Videnović, A., & Jinnah, H. A. (2021) · Movement Disorders · doi:10.1002/mds.28642 · Cited by 23
PACAP and VIP Mitigate Rotenone-Induced Inflammation in BV-2 Microglial Cells
Broome, S. T., Musumeci, G., & Castorina, A. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01968-1 · Cited by 23
Neuronanomedicine for Alzheimer’s and Parkinson’s disease: Current progress and a guide to improve clinical translation
Boyton, I., Valenzuela, S. M., Collins‐Praino, L. E., & Care, A. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.004 · Cited by 23
Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases
Tan, L. Y., Cunliffe, G., Hogan, M. P., Yeo, X. Y., Oh, C., Jin, B., Kang, J., Park, J., Kwon, M., Kim, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380063 · Cited by 23
A Human Brain-Chip for Modeling Brain Pathologies and Screening Blood–Brain Barrier Crossing Therapeutic Strategies
Chim, S. M., Howell, K., Kokkosis, A. G., Zambrowicz, B., Karalis, K. P., & Pavlopoulos, E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16101314 · Cited by 22
Metallic nanomaterials in Parkinson's disease: a transformative approach for early detection and targeted therapy
Mansour, A., Eldin, M. H., & El-sherbiny, I. M. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02428a · Cited by 22
Cell competition from development to neurodegeneration
RODRIGUES, M. C., Couceiro, J., & Moreno, E. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048926 · Cited by 22
Automated analysis of activity, sleep, and rhythmic behaviour in various animal species with the Rtivity software
Silva, R. F. O., Pinho, B. R., Monteiro, N. M., Santos, M. M., & Oliveira, J. M. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-08195-z · Cited by 22
Characterization of preclinical Alzheimer’s disease model: spontaneous type 2 diabetic cynomolgus monkeys with systemic pro-inflammation, positive biomarkers and developing AD-like pathology
Huang, X., Huang, S., Fu, F., Song, J., Zhang, Y., & Yue, F. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01416-9 · Cited by 23
Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
Zaman, Q., Zhang, D., Obireddy, S. R., Wong, W., & Lai, W. (2022) · Aging and Disease · doi:10.14336/ad.2022.0126 · Cited by 22
LINC00943 knockdown attenuates MPP+-induced neuronal damage via miR-15b-5p/RAB3IP axis in SK-N-SH cells
Meng, C., Gao, J. Q., Ma, Q., Sun, Q., & Qiao, T. (2020) · Neurological Research · doi:10.1080/01616412.2020.1834290 · Cited by 21
Use of CRISPR/Cas9-mediated disruption of CNS cell type genes to profile transduction of AAV by neonatal intracerebroventricular delivery in mice
Torregrosa, T., Lehman, S., Hana, S., Marsh, G., Xu, S., Koszka, K., Mastrangelo, N., McCampbell, A., Henderson, C. E., & Lo, S. (2021) · Gene Therapy · doi:10.1038/s41434-021-00223-3 · Cited by 24
Dynamic clinical trial success rates for drugs in the 21st century
Zhou, Y., Zhang, Y., Xu, H., Chen, Z., Huang, S., Li, Y., Fu, J., Zhang, H., Zhao, D., Lian, X., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64552-2 · Cited by 20
A Model of Discovery: The Role of Imaging Established and Emerging Non-mammalian Models in Neuroscience
Haynes, E. M., Ulland, T. K., & Eliceiri, K. W. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.867010 · Cited by 24
Establishment and characterization of human pluripotent stem cells-derived brain organoids to model cerebellar diseases
Brás, J., Henriques, D., Moreira, R., Santana, M. M., Silva-Pedrosa, R., Adão, D., Bráz, S., Álvaro, A. R., de Almeida, L. P., & Mendonça, L. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-16369-y · Cited by 20
Modeling of Neurodegenerative Diseases: ‘Step by Step’ and ‘Network’ Organization of the Complexes of Model Systems
Pasko, V. I., Churkina, A. S., Shakhov, A. S., Kotlobay, A. A., & Alieva, I. B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010604 · Cited by 21
Relationship between enriched environment and neurodegeneration: a review from mechanism to therapy
Xu, Y.-Q., Chen, Y., Xing, J., & Yao, J. (2025) · Clinical Epigenetics · doi:10.1186/s13148-025-01820-4 · Cited by 21

Authors: Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C.
Affiliations: Johns Hopkins University (US)
University of Florida (US)
Corresponding author: Dawson, Ted M.
Golde, Todd E.
ORCID: Dawson, Ted M.
Golde, Todd E.
Lagier-Tourenne, Clotilde
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-09-24
Volume: 21
Issue: 10
Pages: 1370-1379
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/s41593-018-0236-8
PMC: PMC6615039
OpenAlex: W2891411797
Cited by: 576
References: 151
Citations by year: 2026: 59 · 2025: 73 · 2024: 89 · 2023: 72 · 2022: 88 · 2021: 79 · 2020: 70 · 2019: 41 · 2018: 4
FWCI: 6.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG018454, U01AG046139, P50AG047266)
National Cancer Institute (P01CA166009)
National Institute of Neurological Disorders and Stroke (R21NS098006, R01NS087227, R01NS082205, P50NS038377)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: animal models, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, frontotemporal dementia, amyotrophic lateral sclerosis, rodent models, translatability, disease modeling
MeSH terms: Animals, Disease Models, Animal, Humans, Neurodegenerative Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Animal models of neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks